AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAA4. A total of 21 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $10,940,000 | -23.0% | 10,000,000 | 0.0% | 0.09% | -23.9% |
| Q4 2016 | $14,217,000 | +26.0% | 10,000,000 | 0.0% | 0.11% | +39.5% |
| Q3 2016 | $11,285,000 | +2.3% | 10,000,000 | 0.0% | 0.08% | +5.2% |
| Q2 2016 | $11,036,000 | +1.8% | 10,000,000 | 0.0% | 0.08% | +6.9% |
| Q1 2016 | $10,837,000 | -13.9% | 10,000,000 | 0.0% | 0.07% | -10.0% |
| Q4 2015 | $12,580,000 | -21.9% | 10,000,000 | 0.0% | 0.08% | -27.9% |
| Q3 2015 | $16,116,000 | -37.8% | 10,000,000 | 0.0% | 0.11% | -30.6% |
| Q2 2015 | $25,924,000 | +25.2% | 10,000,000 | 0.0% | 0.16% | +23.1% |
| Q1 2015 | $20,703,000 | +23.9% | 10,000,000 | 0.0% | 0.13% | +18.2% |
| Q4 2014 | $16,703,000 | +91.4% | 10,000,000 | +53.8% | 0.11% | +89.7% |
| Q3 2014 | $8,726,000 | +26.1% | 6,500,000 | 0.0% | 0.06% | +31.8% |
| Q2 2014 | $6,918,000 | +4.8% | 6,500,000 | 0.0% | 0.04% | +4.8% |
| Q1 2014 | $6,602,000 | – | 6,500,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 17,250,000 | $19,597,000 | 18.38% |
| STEELHEAD PARTNERS LLC | 17,000,000 | $19,264,000 | 1.88% |
| Bruce & Co., Inc. | 5,500,000 | $6,600,000 | 1.78% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 26,750,000 | $30,177,000 | 1.01% |
| Castle Creek Arbitrage, LLC | 3,721,000 | $4,215,000 | 0.43% |
| LINDEN ADVISORS LP | 7,000,000 | $7,909,000 | 0.36% |
| Sonora Investment Management, LLC | 1,510,000 | $1,702,676,000 | 0.36% |
| BASSO CAPITAL MANAGEMENT, L.P. | 2,110,000 | $2,382,000 | 0.35% |
| WOLVERINE ASSET MANAGEMENT LLC | 18,400,000 | $20,808,000 | 0.31% |
| SSI INVESTMENT MANAGEMENT LLC | 1,975,000 | $2,221,000 | 0.20% |